Management of Hyperglycaemia After Pancreas Transplantation: Are New Immunosuppressants the Answer?

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.2, 2005-01, pp. : 153-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosiglitazone and MI risk - will we ever know the answer?

Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Quantifying Adverse Drug Events: Are Systematic Reviews the Answer?

By Mahyar Etminan Bruce Carleton Paula A. Rochon

Drug Safety, Vol. 27, Iss. 11, 2004-01 ,pp. : 757-761

Adis International

Access to resources Recommend Favorite

Pharmacotherapy Crisis in the Spotlight—Is Open Collaboration Between Academia and Industry the Answer?

By Kaski Juan-Carlos

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 2, 2011-04 ,pp. : 187-188

Springer Publishing Company

Access to resources Recommend Favorite

Can prednisone be withdrawn after renal transplantation?

Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

What's new in disease management?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 252, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite